Loading clinical trials...
Loading clinical trials...
Benefit of Self-sampling for HPV DNA in a General Practitioner's Office to Improve Participation in Cervical Screening - The ASTRA Study.
One of the limitations of organized cervical screening in the Czech Republic is the lack of participation in preventive gynecological examinations. The aim of the project is to evaluate the benefits of self-sampling for HPV DNA in general practitioners' outpatient clinics to improve population participation in cervical screening.
Organized cervical screening in the Czech Republic has a long-term participation rate of about 56% of the target population. Despite active invitations through health insurance companies, a part of the population is resistant and does not participate in screening visits to gynaecologists in the long term. A significant proportion of such women, however, regularly visit their general practitioner due to other comorbidities. The aim of the ASTRA project is to assess whether an effective way to increase the proportion of women attending cervical screening is to perform self-testing for HPV DNA in the GP's office.
Age
30 - No limit years
Sex
FEMALE
Healthy Volunteers
No
CGOP, s.r.o.
Prague, Czechia
Department of Gynecology, Obstetrics and Neonatology, General University Hospital, First Faculty of Medicine, Charles University
Prague, Czechia
Start Date
March 1, 2024
Primary Completion Date
March 1, 2025
Completion Date
June 1, 2025
Last Updated
April 23, 2024
2,000
ESTIMATED participants
HPV DNA self-test
DIAGNOSTIC_TEST
Lead Sponsor
Patient Organization Veronica
NCT06349642
NCT07428330
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions